Abstract
Background and Objectives: The impact of Human immunodeficiency virus (HIV) infection is enormous globally. This study aimed at identifying aspects of clinical and laboratory profile of newly-diagnosed HIV subjects in Owerri, southeast, Nigeria.
Methodology: This was a cross-sectional, descriptive study involving 393 newly-diagnosed HIV subjects and 136 non-HIV, sex- and age-matched Control, consecutively recruited from an HIV clinic and an out-patient clinic of Federal Medical Center, Owerri. Bio-data and anthropometric data were collected. Relevant investigations were performed. Data were compared between HIV subjects and Control.
Results: The mean age of the HIV subjects was 39±11 years and Control 39±12 years. Female/male ratio was 3:1 in boththe HIV subjects and the Control. Mean waist circumference in male HIV subjects was significantly higher than mean WC in male non-HIV Control (p=0.013). Mean high density lipoprotein cholesterol, (p<0.001), serum creatinine, (p=O01), spot urine protein (SUP), (p=0.013), spot urine creatinine, p<0.001), spot urine osmolality, (p<0.001), 24-hour urine protein, (<0.001), 24-hour urine osmolality, (p<0.001), were significantly higher in the HIV subjects than the Control, whereas mean low density lipoprotein cholesterol (p<0.001), hemoglobin, spot urine creatinine/osmolality ratio (p<0.001), 24-hour urine creatinine/osmolality ratio, (p<0.001) were significantly lower in HIV subjects than the Control.
Conclusion: Abnormalities of serum creatinine, urine osmolality, urine protein and serum lipids are common among newly-diagnosed HIV subjects in southeast, Nigeria.
There is need to evaluate HIV patients, at inception, for dyslipidemia, anemia and renal damage.
Keywords: Clinical Characteristics, laboratory profile, HIV patients, Owerri, southeast, Nigeria
References
1. UNAIDS. Gap Report 2014. Page 26
2. Anabel Ki, Jenni F: Graham Pembrey, (ed) HIV and AIDS in Africa. UNAIDS Report 2008.
3. Nochy D, Glotz D, Dosquet P, Pruna A, Guettier C, Weiss L, et al. Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial transpl. 1993; 8(1): 11-19.
4. Okpechi IG, Swanepoel CR. Patterns of renal disease in Cape Town South Africa: a 10 year review of a single center renal biopsy database. J NephrolHypertens. 2011; 25(1): 11-15.
5. Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Eng J Med. 1987; 316(17): 1062-1068.
6. Okecuhukwu Ibeh BO, Omodamiro OD, Ibeh U, Habu JB Biochemical and haematological changes in HIV subjects receiving winnie cure antiretroviral drug in Nigeria. J Biomed Scie 2013, 20: 73 doi:10.1186/1423-0127-20-73
7. Emem CP1, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transpl 2008; 23: 741-746.
8. Agaba EI,Agaba PA,Sirisena ND,Anteyi EA,Idoko JA. Renal disease in the acquired immunodeficiency syndrome in north central Nigeria.Niger J Med. 2003; 12:120-5.
9. Okafor UH, Unuigbe EI, Ojogwu LI, Oviasu E, Wokoma FS. Renal disease in HIV-infected patients at University of Benin Teaching Hospital in Nigeria. Afr Health Sci 2013; 51: 528-533
10. Umeizudike T, Mabayoje M, Okany C, Abdulkareem F, Adeyomoye A, Okubadejo N, Okpechi I. Prevalence of chronic kidney disease in HIV positive patients in Lagos, south-west Nigeria. Nephrology Rev 2012; 4; 22-26.
11. Anyabolu EN, Chukwuonye II, Arodiwe E, Jjoma CK, Ulasi I. Prevalence and Predictors of Chronic Kidney Disease in Newly-diagnosed Human Immuno-deficiency Virus Patients in Owerri, Nigeria. Indian J Nephrol (ahead of print cited 2015 July 28) Available htt://www.indianjnephrol.org/preprintarticle.asp? id=156115
12. Obirikorana C, Yeboah FA. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci. 2009; 16(1): 102.
13. Adewole OO, Eze S, Betiku Ye, Anteyi E, Wada I, Ajuwon Z, et al. Lipid profile in HIV/AIDS patients in Nigeria.Afr Health Sci. 2010 Jun; 10(2): 144–149.
14. Takara LS, Steven KG. Body Composition and Metabolic Changes in HIV-Infected Patients. J Infect Disease. 2015; 205(3): 5383-5390.
15. Waldo HB, Mariana de Paz S, Matilde N, Marisa L, Aeiel G. Impaired Urine Dilution Capability in HIV Stable Patients. Int J Nephrol. 2014; 2014: 381985.
16. Federal Republic of NigeriaGlobal AIDS Response and Progress Report 2012.
17. Akimbani A, Dosumnmu IA, Adeniran IA, Ajibola S,Oshinaike O, et al. CD4 count pattern and demographic distribution of treatment-naïve hiv patients in Lagos, Nigeria. AIDS Res Treatment. 2012; 2012 (2012): 6 pages.
http://dx.doi.org/10.1155/2012/352753
18. Ramjee G, Daniels B. Women and HIV in Sub-Saharan Africa. AIDS Res Therapy. 2013; 10:30 doi:10.1186/1742-6405-10-30
19. Mariz C, Mlitao de Albuquerque, Ximenses RA, Lacerda de Melo R, Bandeira F, et al. Body mass index in individuals with HIV infection and factors associated with thinness and overweight/obesity. Cad. Saude Publica 2011; 27: 10.
20. Mohsen M, Fashid R, Mohammad RM,Majid A, Katayoun T. Prevalence, severity, and related factors of anemia in HIV/AIDS patients. J Res Med Sci. 2012 Feb; 17(2): 138–142.
21. Hylemariam M, Bineyam T, Aster T. Magnitude of Anemia and Associated Factors among Pediatric HIV/AIDS Patients Attending Zewditu Memorial Hospital ART Clinic, Addis Ababa, Ethiopia. Anemia 2015; Vol 2015(2015) http://dx.doi.org/10.1155/2015/479329
22. ShemeshO,Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathy patients. Kid Int 1985; 28: 830-838.
23. Savita RS, Veena G, Shashu L, Himanshu M, Veenu K, Ashuma S. Correlation of 2 Hour, 4 Hour and 12 Hour Urine Protein with 24 Hour Urinary Protein in Preeclampsia.
24. J Family Reprod Heath. 2014 Set, 8(3): 131-134.
25. Kalantari K, Bolten K. A good Reason to Measure 24-Hour Urine Creatinine Excretion, but Not to Assess Kidney Function. Clin J Am SocNephrol. 2013 Nov 7; 8(11): 1847–1849.
DOI: http://dx.doi.org/10.18535/jmscr/v3i12.29
